Neurocritical Care

, 9:259

Safety Issues and Concerns for the Neurological Patient in the Emergency Department

Debates and Arguments



Patient safety in our medical system has been an increasing national concern. Neurological patient safety in the emergency department (ED) has not been studied. The purpose of this article is thus to describe the issues relevant to neurological patient safety in the ED, review the current status of the literature, identify specific patient populations at risk, and suggest applicable solutions.


Medline and PubMed literature review of key words associated with patient safety, neurological diseases, and EDs.


Little data can be found on overall neurological patient safety in the ED, however data for specific neurological emergencies including subarachnoid hemorrhage, stroke, status epilepticus, and head and spine trauma does exist and is reviewed.


Limitations in ED education and access to neurological expertise may place some patients at risk. Recommendations for improving neurological patient safety in the EDs are suggested and include a discussion on barriers to implementation.


Patient safety Neurological emergencies Emergency department 


  1. 1.
    Institute of Medicine. To Err is Human: building a safer health system.; 2000 National Academy of Sciences. Accessed May 2007.
  2. 2.
    Ferro JM, Pinto AN, Falcao I, Rodrigues G, Ferreira J, Falcao F et al. Diagnosis of stroke by the nonneurologist: a validation study. Stroke. 1998;29:1106–9.PubMedGoogle Scholar
  3. 3.
    Glick TH. The neurologist and patient safety. The Neurologist. 2005;11:140–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Kothari RU, Brott T, Broderick JP, Hamilton CA. Emergency physicians: accuracy in the diagnosis of stroke. Stroke. 1995;26:2238–41.PubMedGoogle Scholar
  5. 5.
    Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face, arm, speech test. Stroke. 2003;34:71–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Morgenstern LB, Lisabeth LD, Mecozzi BA, Smith MA, Longwell PJ, McFarling DA et al. A population based study of acute stroke and TIA diagnosis. Neurology. 2004;62:895–900.PubMedGoogle Scholar
  7. 7.
    Libman RB, Wirkowski E, Alvir J, Hemanth RT. Conditions that mimic stroke in the emergency department: implications for an acute stroke trial. Arch Neurol. 1995;52:1119–22.PubMedGoogle Scholar
  8. 8.
    Tissue Plasminogen Activator for Acute Stroke. The National Institute of Neurological Disorders and Stroke ft-PA Stroke study group. N Engl J Med. 1995;333:1581–7.CrossRefGoogle Scholar
  9. 9.
    Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA et al. Use of tissue-type plasminogen activator fro acute ischemic stroke: the Cleveland area experience. JAMA. 2000;9:1151–8.CrossRefGoogle Scholar
  10. 10.
    Ruland S, Gorelick PB, Schneck M, Kim D, Moore CG, Leurgans S. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke. 2002;33:1334–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Hoffman J. IV t-PA interventional therapy for acute stroke patients: negative position. Stroke Intervent. 2002;11:6–10.Google Scholar
  12. 12.
    Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco Rl et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient sample 1999 to 2004. Ann Emerg Med. 2007;50:99–107.PubMedCrossRefGoogle Scholar
  13. 13.
    Adams JG, Chisolm CD. The society of academic emergency medicine position on optimizing care of the stroke patient. Acad Emerg Med. 2003;10:805.PubMedCrossRefGoogle Scholar
  14. 14.
    Jauch E. Society for Academic Emergency Medicine (SAEM) neurologic emergencies interest group response to the SAEM board position on optimizing care of the stroke patient. Acad Emer Med. 2004;11:116–8.Google Scholar
  15. 15.
    Bratina P, Greenberg L, Pasteur W, Grotta JC. Current emergency department management of stroke in Houston Texas. Stroke. 1995;26:409–14.PubMedGoogle Scholar
  16. 16.
    Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurrie C, Biller J. Protocol violations in community based rt-PA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke. 2001;32:12–6.PubMedGoogle Scholar
  17. 17.
    Scott PA, Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator treated patients: characteristics and outcomes. Ann Emerg Med. 2003;42:611–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Renata DG, Novaes HMD, Lorenzi MC, Eluf-Neto J, Okamura MN, Valesco IT. Adverse events and death in stroke patients admitted to the emergency department of a tertiary university hospital. Euro J Emerg. Med. 2005;12:63–71.CrossRefGoogle Scholar
  19. 19.
    Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.PubMedGoogle Scholar
  20. 20.
    Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al. Recombinant activated factor VII intracerebral hemorrhage trial investigators. Recombinant factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777–85.PubMedCrossRefGoogle Scholar
  21. 21.
    Mayer SA, Brun NC, Broderick J, Davis SM, Diringer MN, Skolnick BE et al. United States NovoSeven ICH trial investigators. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. Neurocrit Care. 2006;4:206–314.PubMedCrossRefGoogle Scholar
  22. 22.
    Mayer SA, Brun NC, Begtrup K, Davis S, Diringer MN et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med. 2008;358:2127–37.Google Scholar
  23. 23.
    Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update. Stroke. 2007;38:2001–23.PubMedCrossRefGoogle Scholar
  24. 24.
    Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V et al. Autoregulation of cerebral blood flow surrounding acute (6–22 hours) intracerebral hemorrhage. Neurology. 2001;57:18–24.PubMedCrossRefGoogle Scholar
  25. 25.
    Kassell NF, Konable GL, Torner JC, Adams HP Jr, Mazuz H. Delay in referral of patients with ruptured aneurysms to neurosurgical attention. Stroke. 1985;16:587–90.PubMedGoogle Scholar
  26. 26.
    Mayer PL, Awad IA, Todor R, Harbaugh K, Varnavas G, Lansen TA et al. Misdiagnosis of symptomatic cerebral aneurysms: prevalence and correlation with outcome at four institutions. Stroke. 1996;27:1558–63.PubMedGoogle Scholar
  27. 27.
    Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. New Engl J Med. 2000;342:29–36.PubMedCrossRefGoogle Scholar
  28. 28.
    Kowalski RG, Claasen J, Kreiter KT, Bates JE, Ostapkovich ND, Connolly ES, Mayer SA. Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA. 2004;18:866–9.CrossRefGoogle Scholar
  29. 29.
    Vermeulan MJ, Schull MJ. Missed diagnosis of subarachnoid hemorrhage in the emergency department. Stroke. 2007;38:1216–21.CrossRefGoogle Scholar
  30. 30.
    Edlow JA. Diagnosis of subarachnoid hemorrhage: are we doing better? Stroke. 2007;38:1129–31.Google Scholar
  31. 31.
    Manno EM. New management strategies in the treatment of status epilepticus. Mayo Clin Proc. 2003;78:508–18.PubMedGoogle Scholar
  32. 32.
    Treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of Americas working group on Status Epilepticus. JAMA. 1993;270:854–9.Google Scholar
  33. 33.
    Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40(Suppl 1):S3–S8.PubMedCrossRefGoogle Scholar
  34. 34.
    Theodore WH, Porter RJ, Alpert P, Kelley K, Bromfield E, Devinsky O et al. The secondary generalized tonic-clonic seizure: a videotape analysis. Neurology. 1994;44:1403–7.PubMedGoogle Scholar
  35. 35.
    Treiman DM. Status epilepticus. Baillieres Clin Ceurol. 1996;5:821–39.Google Scholar
  36. 36.
    Walker MC, Cockerell OC, Sander JWAS. Non-convulsive status epilepticus presenting as a psychiatric condition. J R Soc Med. 1996;89:91–2.PubMedGoogle Scholar
  37. 37.
    Holtkamp M, Othman J, Buchheim K, Meierkord H. Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology. 2006;66:1727–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Whitaker JN. The confluence of quality of care, cost-effectiveness, pragmatism, and medical ethics in the diagnosis of nonepileptic seizures: a provocative situation in neurology. Arch Neurol. 2001;58:2066–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Dworetzky BA, Bromfield EB. Differential diagnosis of status epilepticus: Pseudostatus epilepticus, Chapter 3. In: Drislane FW, editor. Status Epilepticus: a clinical perspective. New Jersey: Humana Press Towata; 2005. p. 33–54.Google Scholar
  40. 40.
    Alldredge BK, Gelb AM, Issacs SM et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out of hospital status epilepticus. NEJM. 2001;345:631–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Bulger EM, Nathens AB, Rivara FP, Moore M, Mac Kenzie EJ, Jurkovich GJ. Management of severe head injury: institutional variations in care and effect on outcome. Crit Care Med. 2002;30:1870–76.Google Scholar
  42. 42.
    Vellman P, Hawkws AP, Lammertse DP. Administration of corticosteroids for acute spinal cord injury: the current practice of trauma medical directors and emergency medical system physician advisors. Spine. 2003;28:941–947.CrossRefGoogle Scholar
  43. 43.
    Muolin T, Berger E, Lemounaud P, Vuillier F, Tatu L, Sablot D et al. Consultation de neurolgie en urgence dans un centre hospitalier universitaire: apport du neurologue dans la prose en charge du patient. Rev Neurol (Paris). 2000;156:727–35.Google Scholar
  44. 44.
    Bray JE, Martin J, Cooper G, Barger B, Bernard S, Blandin C. An interventional study to improve paramedic diagnosis of stroke. Prehospital Emerg Care. 2005;9:297–392.CrossRefGoogle Scholar
  45. 45.
    Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke. A Cleveland update. Stroke. 2003;34:799–800.PubMedCrossRefGoogle Scholar
  46. 46.
    Morgenstern LB, Bartholomew K, Grotta JC, Straub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase stroke therapy. Arch Intern Med. 2003;163:2198–202.PubMedCrossRefGoogle Scholar
  47. 47.
    Wibborg A, Widder B, for the TESS Study group. Teleneurology to improve stroke care in rural areas. The telemedicine in stroke in Swabia (TESS) project. Stroke. 2003;34:2951–7.CrossRefGoogle Scholar
  48. 48.
    Wang DZ. Telemedicine: the solution to provide rural stroke coverage and the answer to the shortage of stroke neurologists and radiologists. Stroke. 2003;34:2957.PubMedCrossRefGoogle Scholar
  49. 49.
    Burstin HR, Conn A, Setnik G, Rucker DW, Cleary PD, O'Nell AC et al. Benchmarking and quality improvement: the Harvard emergency department quality study. Am J Med. 1999;107:437–49.PubMedCrossRefGoogle Scholar
  50. 50.
    Physicians Insurers Association of America (PIAA). Neurology Claims (300 Paid Claims Study). Rockville, MD: PIAA; 2004.Google Scholar
  51. 51.
    Stettler BA, Jauch EC, Kissela B, Lindsell CJ. Neurologic education in emergency medicine training programs. Acad Emerg Med. 2005;12:909–11.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2008

Authors and Affiliations

  1. 1.Department of NeurologyMayo Clinic College of MedicineRochesterUSA

Personalised recommendations